API Product

Mometasone Furoate Anhydrous

mometasone-furoate-anhydrous
Product Status:
Commercial
Available Grades:
  • Inhalation
  • Micronized
  • Non-Micronized
Regulatory Status:
CEP
US DMF
Production Sites:
  • Hovione Loures
Product Type:
  • Corticosteroids
CAS Number:
83919-23-7
Modes of Application:
  • Lung and Nasal administration
  • Topical
Common Indications:
  • Allergic rhinitis
  • Asthma
  • Skin disorders
High performance APIs for inhalation as well as other demanding applications.  The diversity and experience in particle size reduction technologies provides our Customers with tailored made, highly reproducible particle size distributions. Low amorphous content and high stability with an industry leading impurity profile are also part of our offering.

This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties’ patent rights.

Related files

Hovione Product Portfolio
pdf (84.51 KB)
Download